Related Experiment Video
Updated: Feb 3, 2026

Untargeted Liquid Chromatography-Mass Spectrometry-Based Metabolomics Analysis of Wheat Grain
Published on: March 13, 2020
Evidence of a Synergistic Effect between Pea Seed and Wheat Grain Endogenous Phytase Activities
Alaeddine Chouchene1, Valerie Micard1, Valerie Lullien-Pellerin1
1Ingénierie des Agropolymères et Technologies Émergentes , Institut National de la Recherche Agronomique, Montpellier SupAgro, Université de Montpellier, and Centre de Coopération Internationale en Recherche Agronomique pour le Développement , 34060 Montpellier , France.
Abstract:
Distribution of phytic acid and phytase activity in pea seeds was analyzed and compared with those in wheat grains under identical assay conditions (55 °C, pH 5.5). Most total phytic acid content and phytase activity were found in pea cotyledons. In wheat grains, debranning resulted in a 70% reduction in phytic acid content, whereas more than 40% of the total phytase activity remained. The possibility to hydrolyze phytic acid by use of ground debranned wheat as a source of phytase in blends with pea cotyledon flour was investigated. The Michaelis-Menten parameters for each endogenous enzyme were identified and used to predict the rate of phytic acid hydrolysis. Results demonstrate a synergistic effect between the two phytase activities, enabling a 70-95% reduction of phytic acid depending on pea/wheat flour ratios in a relatively short time (4 h). This reduction appears to be able to increase zinc bioavailability but remains insufficient for iron.
Related Concept Videos
The Evidence for Evolution
Seed Structure and Early Development of the Sporophyte
Introduction to Seed Plants
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Co-activators and Co-repressors

